Background: Post-chemotherapy retroperitoneal lymphadenectomy (PC-RPLND) represents the treatment of choice in patients with residual masses following chemotherapy for metastatic germ cell tumours. Involvement of major retroperitoneal vessels or thoracic/lumbar spine is rare and challenging but needs complete resection for curative intent. We report on our experience in the management of such complex cases.
Introduction
Systemic cisplatin-based chemotherapy followed by postchemotherapeutic resection of residual masses represents the guideline recommended therapeutic approach of choice for patients with advanced metastatic testicular germ cell tumours (TGCT) [1] . Complete resection of all residual masses independent on size and location represents the major goal of PCR in non-seminomatous TGCT in order to resect occult viable and teratomatous elements. Incomplete resection is associated with an increased frequency of in-field relapses and it also contributes to a significantly reduced long-term survival rate of only 25-30% [2] .
At time of post-chemotherapeutic retroperitoneal lymph node dissection (PC-RPLND) of large residual masses the resection of adjacent vascular and organ structures becomes necessary in about one fourth of all patients. Ipsilateral nephrectomy is the most common type of adjunctive surgeries in about 5-10% of patients [3, 4] . Resection of the infrarenal abdominal aorta or the inferior vena cava is to be performed in up to 6% of patients and resection of the small bowel segments and the ureter are reported in 2-4% of patients [5] [6] [7] [8] [9] [10] [11] [12] .
The resection of vertebral bodies of the thoracic or the lumbar spine is rarely indicated with only very few cases are published in the literature [13] [14] [15] [16] . Involvement of the duodenum and/or pancreas with the necessity of resection has not been reported in the literature to the best of our knowledge.
In these above mentioned, complex situations, a multidisciplinary approach is indicated in order to resecting the masses completely with a minimum of perioperative complications.
It is our purpose to report the pre-, intra-and peri-operative management of such a multidisciplinary approach in a highly selected cohort of patients treated at a tertiary referral centre.
Patients and methods
Between 1/2009 and 12/2015, 185 PC-RPLNDs were performed in patients with residual masses following systemic chemotherapy of metastatic TGCT. At time of surgery serum, concentrations of the tumour markers AFP, b-hCG and LDH were normalized or they had experienced a plateau. About 121 (65.4%) patients did undergo primary chemotherapy prior to PC-RPLND whereas 51 (27.6%) and 13 (7.0%) patients had received salvage chemotherapy and high dose chemotherapy, respectively. PC-RPLND was performed as the first surgery or as redo surgery for local relapses in 151 (81.6%) and 34 (18.4%) patients, respectively.
Patient characteristics are listed in Table 1 . Pre-operatively, involvement of the major retroperitoneal vessels was anticipated in 26 (16.04%) patients based on the findings of the abdominal CT scan. In 10 patients, a MRI of the abdomen was additionally performed in order to better delineate the inferior vena cava.
In three patients, involvement of the vertebral bodies was anticipated on preoperative CT images; in one patient teratoma was diagnosed after CTguided biopsy of the vertebral body. In four patients, first and second lumbar vertebra were involved and in one patient the 12th thoracic vetebra was infiltrated. Preoperatively a CT scan and a MRI scan were performed for adequate evaluation of the skeletal structures and to rule out spinal cord involvement.
Follow-up examinations were performed at 3-months intervals for a total of 2 years, at 4-months intervals during year 3, at 6-months intervals during year and at annual intervals starting at year 5 and consisted of (1) measurement of serum concentrations of AFP, b-hCG and LDH, (2) ultrasonography of the remaining testis, (3) computed tomography of the chest, abdomen and the small pelvis and (4) a physical examination. After 2011, follow-up was performed according to the recommendations of the German Testicular Cancer Study Group [17] . In case the follow-up procedures were not done in our department, follow-up schemes were communicated with the treating physician. These patients were contacted regularly at 3-months intervals by mail to obtain information concerning surgery-related complications, relapses, treatment of relapses and survival.
The retrospective analysis of our cohort comprises the evaluation of surgery-related complications according to the Clavien-Dindo classification and cancer-specific parameters such as progression-free, overall and cancerspecific survival [18, 19] . The complications rates and the oncological outcome data were compared to a group of PC-RPLND patients without adjunctive surgeries. Calculation of survival data was done according to the KaplanMeier method [20] . Statistical was done with a paired t-test and the ChiSquare test using the SPSS statistical program.
Results
A total of 25 (13.5%) patients have been identified who underwent complex adjunctive surgical procedures to achieve complete resection of residual masses. Two (80%) and five (20%) patients had a non-seminomatous and a seminomatous primary GCT, respectively. Adjunctive vascular surgery was necessary in 16 (8.64%) patients. Five (2.7%) and four (2.2%) patients underwent resection and replacement of vertebral bodies or a pancreaticodudenal resection in terms of s Whipple's procedure, respectively. Patient characteristics are listed in Table 1 .
Vascular surgery
Involvement of the IVC and the abdominal aorta was identified in 11 (5.94%) and 5 (2.7%) patients, respectively (supplementary Figures S1 and S2, available at Annals of Oncology online). The surgical technique is described in the supplementary Material S1, available at Annals of Oncology online. In two patients, complete resection of the IVC from the renal veins to the common iliac veins was performed due to extensive infiltration (supplementary Figures S3 and S4 , available at Annals of Oncology online). IVC was replaced with a prosthesis due to non-existent collaterals and the patients were put on anticoagulation with cumarin. In seven patients, partial resection of the IC wall was indicated due to an infiltration with or without the presence of an ICV thrombus (n ¼ 3).
Two patients underwent the resection and graft replacement of the common iliac vein and the common iliac artery due to the infiltration with teratoma.
The mean surgery time was 5.6 (2.8-9.2) h and the mean blood loss was 450 (150-750) cc. None of the patients needed blood transfusions perioperatively. Pathohistology revealed mature teratoma, embryonal carcinoma and seminoma residues infiltrating the ICV wall. IVC thrombi consisted of mature teratoma which derived from direct infiltration of the residual masses. In the five cases with an aortic resection teratoma, embryonal carcinoma and seminoma was identified in three, one and one patients, respectively.
After a mean follow-up of 3.4 years, one patient developed a relapse and all patients are alive. Both IVC prosthesis clotted despite anticoagulation.
Skeletal surgeries
Resection of the vertebral bodies was performed in five (2.7%) patients. In four patients, primary PC-RPLND was performed and in one patient a chemorefractory, retrocrural marker negative, late relapse 31 years after initial diagnosis infiltrating the first lumbar vertebral body necessitated resection and replacement of the vertebral body (supplementary Figures S5 and S6 , available at Annals of Oncology online). The surgical technique is described in supplementary Material S2, available at Annals of Oncology online.
Mean surgical time of the first session was 2.6 (2-4) h. Mean surgical time of the second session was 8.7 (7-11) hours, the mean intraoperative blood loss was 950 (600-2500) ml. The application of a mean number of 3 (3-8) red blood cell transfusions was necessary in three patients. Mean time of hospitalization was 12 (8-32) days.
Pathohistology revealed the following results: case 1: combination of teratoma and embryonal carcinoma in the lymph nodes and malignant somatic transformation in the vertebra; case 2 with teratoma in the lymph nodes and necrosis/fibrosis in the vertebra; case 3 with embryonal carcinoma in the lymph nodes and necrosis in the vertebra, case 4 with teratoma in both specimens and case 5 with teratoma in the lymph nodes and MST in the vertebra.
The mean follow-up is 27 (12-43) months, overall survival and progression-free survival is 100% and 60%, respectively. Both relapsing patients had MST in their specimens.
Pancreaticoduodenal adjunctive surgery
Pancreaticoduodenal resection was performed in four (2.2%) patients of whom three patients underwent partial pancreatic resection with biliodigestive anastomosis (supplementary Material S3, available at Annals of Oncology online). In all patients, extensive suprahilar paacaval and paraaortic residual masses were present on preoperative imaging studies. All patients had cisplatin-refractory, marker negative lesions after 2-4 cytotoxic regimes including high dose chemotherapy. In two patients, late relapses 3.5 and 32 years following the last cytotoxic regime resulted in pancreaticoduodenal involvement. All of the four patients had undergone radical bilateral infrahilar PC-RPLND before and in all patients the retroperitoneum was free of disease.
Mean surgery time was 7.5 (6.4-9.5) h. The mean intraoperative blood loss was 650 (400-1350) ml and two patients received two blood transfusions intraoperatively. The mean time of hospitalisation was 24 days.
Pathohistologic analysis demonstrated vital carcinoma in all four patients: classical seminoma, teratoma, malignant somatic transformation and a combination of teratoma and acinar cell carcinoma of the pancreas.
The mean follow-up is 18 (12-28) months; overall survival and progression-free survival are 75% and 75%, respectively.
Other types of adjunctive surgeries are given in supplementary Material S4, available at Annals of Oncology online.
Complications of PC-RPLND
Compared to the group of patients without adjunctive surgeries, surgery related complications were observed significantly more often (41.7% versus 7.2%, P ¼ 0.02). On the other hand, redo PC-RPLND, resection of chemorefractory disease and resection of late relapses after multiple courses of chemotherapy had to be done significantly more often than in the group without adjunctive surgeries (70.8% versus 10.9%, P ¼ 0.01).
Frequency and severity of complications strongly correlated with the type of adjunctive surgeries (Tables 2 and 3 ): whereas we did not observe statistically significant differences between PC-RPLND without or with vascular and skeletal surgeries, patients with pancreaticoduodenal surgeries developed more severe complications ( Table 2) . Management of Complications is given in supplementary Material S5, available at Annals of Oncology online.
Discussion
PC-RPLND represents an integral part of the multimodality treatment of metastatic testicular germ cell tumours with the primary goal to completely resect the residues with curative intent [1, 12] . Dependent on the location and the extent of the disease standard and complex PC-RPLND have to be differentiated with the latter one comprises redo RPLNDs, salvage and desperation surgeries and patients with incompletely resectable tumours [21, 22] . Patients who need to undergo complex PC-RPLND procedures might harbour vital cancer and teratoma in 40-50% resulting in a lower long-term survival rate of only about 65% [11] . Frequency and type of perioperative complications vary significantly between both groups and are reported to be as high as 60% in complex PC-RPLNDs [5, 8, 23] . These data are also reflected in our series with a complication rate of 41.7% although it has to be emphasized that the majority of surgery-associated complications did not exceed Clavien-Dindo grade IIIB and that nearly all of them could be managed conservatively.
In our series, the oncological benefit is clearly substantiated by the fact that all patients exhibited significant pathology such as teratoma, vital cancer and somatic malignant transformation. Furthermore, only the three patients with MTS developed recurrences which were treated with a histology-adapted cytotoxic regime [24] [25] [26] .
Besides the survival issue, it might be discussed if the potentially increased risk of surgery-related morbidity associated with the resection of adjacent organs justifies complex PC-RPLND. A careful analysis of our patient cohort did not reveal a statistically significant difference between standard PC-RPLND and complex PC-RPLND concerning the severity of complications. However, we did observe an increased severity of complications following pancreaticoduodenal surgeries so that we would recommend such procedures and a PC-RPLND in general only in the clinical scenario of both a highly experienced multidisciplinary team.
With regard to the potential involvement of the inferior vena cava or the abdominal aorta multiple cytotoxic regimes, the presence of cisplatin refractory germ cell tumours or residual masses encasing the aorta by more than 50% are risk factors making adjunctive vascular surgery most likely. In a retrospective study the German Testicular Cancer Study Group has identified the presence of intermediate or poor risk germ cell tumours and the presence of residual masses >5 cm in diameter to be associated with an 4.61-fold increased risk of vascular involvement [9] . Every fifth patient exhibiting one of the above-mentioned criteria needed some type of vascular surgery. Preoperatively, a MRI of the retroperitoneum might predict involvement of the IVC [27] . We could verify these parameters in the present series which always results in the specific surgical approach securing the large vessels with tourniquets in order to enable complete resection in a bloodless field even if the vascular structures would be injured during surgery (supplementary Figure S1a , available at Annals of Oncology online).
In our series, three patients demonstrated intracaval tumour thrombi and another three patients exhibited vital germ cell tumour elements in the wall of the IVC so that the resection of vascular structures is mandatory to achieve complete resection (supplementary Figure S2a , b, available at Annals of Oncology online). Similar data were reported by Johnston et al. [11] who identified intracaval tumour thrombi in 5.8% of patients undergoing complex PC-RPLND. Half of the patients demonstrated vital cancer or teratoma in the resected thrombi. About 90% of patients with intracaval tumour thrombi had a right sided primary so that either tumour emboli or continuous growth inside the testicular vein might be responsible. These considerations underline the specific importance to always resect the ipsilateral testicular vein and the intrapelvic portion of the vas deferens which might harbour residual disease giving rise to paracolic recurrences [28] .
Complete infrarenal resection of the IVC usually can be performed without prosthetic replacement due to the existing collaterals and without the need of lifelong anticoagulation still resulting in a fairly high rate of IVC-thrombosis [10] .
With regard to aortic involvement various predictors are discussed in the literature as described above [8, 9, 29, 30] . Preoperative interdisciplinary counselling and intraoperative adaptation of the surgical technique are mandatory to ensure a safe and complete resection of the masses. In patients with complex PC-RPLNDS the majority of vascular specimens demonstrate a significant pathohistology (teratoma, vital cancer, MTS) whereas about 25-33% of patients undergoing standard PC-RPLND demonstrate necrosis or fibrosis in the vascular specimens [6, [8] [9] [10] [11] . Furthermore, it was shown in earlier series that complete resection of the aorta results in a significantly reduced surgery-associated morbidity and an improved oncological outcome [8] . In our series, none of the patients experienced significant complications when potential aortic involvement was anticipated preoperatively resulting in complete aortic resection and replacement. This approach resembles the experience of other groups underlining the fact that surgical experience probably matters the most in complex PC-RPLND. In our series, five patients demonstrated involvement of the thoracolumbar spine which either resulted in significant clinical symptoms or in pathological fractures. Skeletal involvement of the spine is described in 3% and 9% of patients with primary and relapsing GCT [16] . In 90%, the lumbar spine is involved due to continuous infiltration of large paraaortic and retroaortic masses as it has been the case in our patients. However, there are only a few cases reported in whom a combined approach of PC-RPLND with skeletal surgery was performed [13] [14] [15] . We identified vital cancer with malignant somatic transformation or teratoma in four cases and only one patients exhibited scar tissue as the only pathohistological finding. All cases with MST represented relapses after first-and/or second-line therapy so that a combined surgical approach seems to be justified without more detailed diagnostic approaches such as a CT-guided biopsy of the osseous lesion. In patients with suspected but asymptomatic skeletal lesions following first line chemotherapy we recommend a CT-guided biopsy prior to any surgical approach. In any case, a close interdisciplinary discussion is mandatory to identify the most beneficial imaging studies and to coordinate the most appropriate therapeutic and surgical strategy.
When it comes to the adjunctive resection of small bowel, none of the series described the combined surgical approach of PC-RPLND with a pancreaticoduodenal resection and a Whipple's procedure [13] . This might be due the rarity of the presence of a suprahilar lymph node with pancreatic infiltration and still complete resectability. We have performed the en-bloc resection of lymph nodes, pancreas and duodenum resulting in a complete resection of the residual masses in all patients. Based on the significant pathohistology of the resected pancreatic specimens in all four patients and the progression-free survival in three patients, this aggressive surgical approach seems to be justified. All patients exhibited solitary, chemorefractory lymph nodes after multiple cytotoxic regimes and previous standard PC-RPLND so that surgery was the only curative treatment option. However, even in experienced hands, this type of surgery is associated with an increased risk of significant treatment-associated complications so that it needs to be performed at tertiary referral centres.
A total of three patients exhibited MST which might occur in up to 6% of all metastatic GCT [24] [25] [26] . The most common histologies of MST include sarcoma, adenocarcinoma and priomitive neuroectodermal tumours. The prognosis is usually poor and treatment remains a challenge due to the refractoriness to cisplatin-based chemotherapy and radiation. It is suggested that the choice of chemotherapy and locoregional management in relapsing GCT with MST still should be cisplatin-based secondline treatment [24] [25] [26] .
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